• Return to Headlines

Watch for Continued Gains in Shares of Aerie Pharmaceut (AERI)

By Shiri Gupta

Shares of Aerie Pharmaceut (NASDAQ:AERI) traded at a new 52-week high today of $73.90. Approximately 75,000 shares have changed hands today, as compared to an average 30-day volume of 480,000 shares.

Aerie Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The Company discovers, develops, and distributes pharmaceutical products for the treatment of glaucoma and other diseases of the eye. Aerie Pharmaceuticals serves customers worldwide.

In the past 52 weeks, Aerie Pharmaceut share prices have been bracketed by a low of $47.05 and a high of $73.90 and are now at $72.95, 55% above that low price. The 200-day and 50-day moving averages have moved 0.58% higher and 2.22% higher over the past week, respectively.

There is potential upside of 12.8% for shares of Aerie Pharmaceut based on a current price of $72.95 and an average consensus analyst price target of $82.30. The stock should find initial support at its 50-day moving average (MA) of $59.02 and further support at its 200-day MA of $57.75.

SmarTrend is tracking the current trend status for Aerie Pharmaceut and will alert subscribers who have AERI in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows aerie pharmaceut

Ticker(s): AERI